Market Cap 926.06M
Revenue (ttm) 606.88M
Net Income (ttm) -225.68M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -37.19%
Debt to Equity Ratio 0.27
Volume 1,818,300
Avg Vol 2,300,460
Day's Range N/A - N/A
Shares Out 759.07M
Stochastic %K 67%
Beta 1.49
Analysts Strong Sell
Price Target $2.38

Company Profile

OPKO Health, Inc. operates as a healthcare company, in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company operates in two segments, Pharmaceutical and Diagnostics. The Pharmaceutical segment develops MDX2001, a tetra-specific antibody targeting several types of solid tumors in Phase 1 clinical trials; MDX2003, a tetra-specific antibody targeting two antigens for hematological tumors in Phase 1 clinical trials; and MDX2004, a trispecific immune modulator to...

Industry: Diagnostics & Research
Sector: Healthcare
Phone: 305 575 4100
Address:
4400 Biscayne Boulevard, Miami, United States
Gasbagger
Gasbagger Apr. 25 at 2:42 PM
$OPK Buyers Beware! Make sure you do your Own DD on Opko so you can form your own conclusion. Start buy Googling P Frost and SEC Penny Stock Fraud.
0 · Reply
invest2bfree
invest2bfree Apr. 24 at 10:00 PM
$OPK has anybody looked at those 1/27 1.50$ c? They are building momentum.
0 · Reply
Gasbagger
Gasbagger Apr. 24 at 9:00 PM
$OPK another week of cash burn. Tic Tock !ModeX and its Mstar Platform have done nothing but drive Opko to its all time lows. Which it has never recovered.
0 · Reply
barnabasreynolds
barnabasreynolds Apr. 24 at 2:57 AM
$OPK wow same old names posting away. There are other stocks to trade guys.
0 · Reply
SuperGreenToday
SuperGreenToday Apr. 24 at 1:40 AM
$OPK Share Price: $1.23 Contract Selected: Dec 18, 2026 $1.5 Calls Buy Zone: $0.11 – $0.14 Target Zone: $0.20 – $0.25 Potential Upside: 66% ROI Time to Expiration: 238 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
tymtested
tymtested Apr. 24 at 1:05 AM
$OPK another gasbasher nonsense post.
0 · Reply
Gasbagger
Gasbagger Apr. 23 at 6:42 PM
$OPK sold two thirds of Brli ,sold GeneDx,sold the pill plant in Ireland, and borrowed on future Ngenla sales and Shareholders received Nothing. Anyone that thinks Opko will be bought out is dreaming that they will get a payout from Opko. Past performance proves that. They haven't shared yet, so why would they start now?
0 · Reply
tymtested
tymtested Apr. 23 at 2:28 PM
$OPK OPKO's destiny is to be sold. The market doesnt really know the value of OPKO so it trades on some low trend until whoever that future buyer is, recognizes the value of OPKO and makes an offer. At that point the stock will sky rocket by points. Meantime, long investors simply need the OPKO team to keep doing things to increase the value of OPKO with general disregard for market gyrations. GO OPKO!!
0 · Reply
tradertrash
tradertrash Apr. 23 at 2:11 PM
$OPK if u want to sit for years and watch mgt get wealthy, if u like holding dead money, if u like watching public money being used to run a private empire, if u like not having a bod that works for sh, if u like having fines paid by the CO for wrong doing, if u like dilution, if u like failed products, if u don't like a roi, if u like overspending, if u like aquiring more sh*t when the sh*t u already have is a failure, if u like the same tired azz strategy that has been a loser for sh for years to continue,
0 · Reply
Gasbagger
Gasbagger Apr. 23 at 1:01 AM
$OPK The 4Kscore Prostate Test was promoted by Opko as a Life Saver ! That it would save many lives. Why havent we heard at least one life saving story ? You would think there would be at least one if not 101 the way Opko promoted it.
2 · Reply
Latest News on OPK
OPKO Health Earnings Call Transcript: Q4 2025

Feb 26, 2026, 4:30 PM EST - 2 months ago

OPKO Health Earnings Call Transcript: Q4 2025


OPKO Health Earnings Call Transcript: Q3 2025

Oct 29, 2025, 4:30 PM EDT - 6 months ago

OPKO Health Earnings Call Transcript: Q3 2025


OPKO Health Earnings Call Transcript: Q2 2025

Jul 31, 2025, 4:30 PM EDT - 9 months ago

OPKO Health Earnings Call Transcript: Q2 2025


NextPlat Issues Interim CEO Update Shareholder Letter

Jun 30, 2025, 8:01 AM EDT - 10 months ago

NextPlat Issues Interim CEO Update Shareholder Letter

NXPL


OPKO Health Earnings Call Transcript: Q1 2025

Apr 30, 2025, 4:30 PM EDT - 1 year ago

OPKO Health Earnings Call Transcript: Q1 2025


OPKO and Entera partner to develop obesity pill

Mar 17, 2025, 8:57 AM EDT - 1 year ago

OPKO and Entera partner to develop obesity pill


OPKO Health Earnings Call Transcript: Q4 2024

Feb 27, 2025, 4:30 PM EST - 1 year ago

OPKO Health Earnings Call Transcript: Q4 2024


OPKO Health Earnings Call Transcript: Q3 2024

Nov 7, 2024, 4:30 PM EST - 1 year ago

OPKO Health Earnings Call Transcript: Q3 2024


OPKO Health Earnings Call Transcript: Q2 2024

Aug 7, 2024, 4:30 PM EDT - 1 year ago

OPKO Health Earnings Call Transcript: Q2 2024


OPKO Health Earnings Call Transcript: Q1 2024

May 7, 2024, 4:30 PM EDT - 2 years ago

OPKO Health Earnings Call Transcript: Q1 2024


OPKO Health Earnings Call Transcript: Q4 2023

Feb 27, 2024, 4:30 PM EST - 2 years ago

OPKO Health Earnings Call Transcript: Q4 2023


OPKO Health Earnings Call Transcript: Q3 2023

Nov 6, 2023, 4:30 PM EST - 2 years ago

OPKO Health Earnings Call Transcript: Q3 2023


OPKO Health Earnings Call Transcript: Q2 2023

Aug 3, 2023, 4:30 PM EDT - 2 years ago

OPKO Health Earnings Call Transcript: Q2 2023


OPKO Health Earnings Call Transcript: Q1 2023

May 3, 2023, 4:30 PM EDT - 3 years ago

OPKO Health Earnings Call Transcript: Q1 2023


OPKO Health Transcript: R&D Day 2023

Mar 20, 2023, 4:00 PM EDT - 3 years ago

OPKO Health Transcript: R&D Day 2023


OPKO Health Earnings Call Transcript: Q4 2022

Feb 23, 2023, 4:30 PM EST - 3 years ago

OPKO Health Earnings Call Transcript: Q4 2022


OPKO Health Transcript: JPMorgan Healthcare Conference

Jan 11, 2023, 7:30 PM EST - 3 years ago

OPKO Health Transcript: JPMorgan Healthcare Conference


OPKO Health Earnings Call Transcript: Q3 2022

Nov 8, 2022, 7:45 AM EST - 3 years ago

OPKO Health Earnings Call Transcript: Q3 2022


OPKO Health Earnings Call Transcript: Q2 2022

Aug 3, 2022, 10:55 PM EDT - 4 years ago

OPKO Health Earnings Call Transcript: Q2 2022


OPKO Health Earnings Call Transcript: Q1 2022

May 9, 2022, 2:17 PM EDT - 4 years ago

OPKO Health Earnings Call Transcript: Q1 2022


OPKO Health Earnings Call Transcript: Q4 2021

Feb 24, 2022, 12:06 PM EST - 4 years ago

OPKO Health Earnings Call Transcript: Q4 2021


OPKO Health Earnings Call Transcript: Q3 2021

Oct 28, 2021, 12:05 PM EDT - 4 years ago

OPKO Health Earnings Call Transcript: Q3 2021


OPKO Health Earnings Call Transcript: Q2 2021

Jul 28, 2021, 8:00 PM EDT - 5 years ago

OPKO Health Earnings Call Transcript: Q2 2021


OPKO Health Earnings Call Transcript: Q1 2021

Apr 28, 2021, 2:39 AM EDT - 5 years ago

OPKO Health Earnings Call Transcript: Q1 2021


Gasbagger
Gasbagger Apr. 25 at 2:42 PM
$OPK Buyers Beware! Make sure you do your Own DD on Opko so you can form your own conclusion. Start buy Googling P Frost and SEC Penny Stock Fraud.
0 · Reply
invest2bfree
invest2bfree Apr. 24 at 10:00 PM
$OPK has anybody looked at those 1/27 1.50$ c? They are building momentum.
0 · Reply
Gasbagger
Gasbagger Apr. 24 at 9:00 PM
$OPK another week of cash burn. Tic Tock !ModeX and its Mstar Platform have done nothing but drive Opko to its all time lows. Which it has never recovered.
0 · Reply
barnabasreynolds
barnabasreynolds Apr. 24 at 2:57 AM
$OPK wow same old names posting away. There are other stocks to trade guys.
0 · Reply
SuperGreenToday
SuperGreenToday Apr. 24 at 1:40 AM
$OPK Share Price: $1.23 Contract Selected: Dec 18, 2026 $1.5 Calls Buy Zone: $0.11 – $0.14 Target Zone: $0.20 – $0.25 Potential Upside: 66% ROI Time to Expiration: 238 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
tymtested
tymtested Apr. 24 at 1:05 AM
$OPK another gasbasher nonsense post.
0 · Reply
Gasbagger
Gasbagger Apr. 23 at 6:42 PM
$OPK sold two thirds of Brli ,sold GeneDx,sold the pill plant in Ireland, and borrowed on future Ngenla sales and Shareholders received Nothing. Anyone that thinks Opko will be bought out is dreaming that they will get a payout from Opko. Past performance proves that. They haven't shared yet, so why would they start now?
0 · Reply
tymtested
tymtested Apr. 23 at 2:28 PM
$OPK OPKO's destiny is to be sold. The market doesnt really know the value of OPKO so it trades on some low trend until whoever that future buyer is, recognizes the value of OPKO and makes an offer. At that point the stock will sky rocket by points. Meantime, long investors simply need the OPKO team to keep doing things to increase the value of OPKO with general disregard for market gyrations. GO OPKO!!
0 · Reply
tradertrash
tradertrash Apr. 23 at 2:11 PM
$OPK if u want to sit for years and watch mgt get wealthy, if u like holding dead money, if u like watching public money being used to run a private empire, if u like not having a bod that works for sh, if u like having fines paid by the CO for wrong doing, if u like dilution, if u like failed products, if u don't like a roi, if u like overspending, if u like aquiring more sh*t when the sh*t u already have is a failure, if u like the same tired azz strategy that has been a loser for sh for years to continue,
0 · Reply
Gasbagger
Gasbagger Apr. 23 at 1:01 AM
$OPK The 4Kscore Prostate Test was promoted by Opko as a Life Saver ! That it would save many lives. Why havent we heard at least one life saving story ? You would think there would be at least one if not 101 the way Opko promoted it.
2 · Reply
BarryLong28
BarryLong28 Apr. 22 at 10:19 PM
$OPK Been a while since I bought this, but decided to get back in today!
0 · Reply
Gasbagger
Gasbagger Apr. 22 at 8:09 PM
$OPK Rayaldee was first in class too ! LOL!
1 · Reply
Sierradude
Sierradude Apr. 22 at 7:51 PM
$OPK CAR T cell therapies already exist. Trust me, I have CLL so I know a thing or two about treating lymphomas. These medicines take a lot of time to get through to a phase three trial. Most believe that CLL will be cured within ten years. New BTK inhibitors work extremely well and are much easier on the patient.
1 · Reply
tymtested
tymtested Apr. 22 at 7:15 PM
$OPK first-in-class tetraspecific T-cell engager,
1 · Reply
tymtested
tymtested Apr. 22 at 7:10 PM
0 · Reply
Gasbagger
Gasbagger Apr. 22 at 7:03 PM
$OPK who remembers when Frost and Friends spent 25 million on a Rayaldee trial to see if it worked for Covid ? It is called an R&D money grab. Why wont they bring in the Forensic Accounts to police the books.
0 · Reply
Gasbagger
Gasbagger Apr. 22 at 6:57 PM
$OPK There are several FDA-approved drugs and therapies for relapsed or refractory B-cell lymphoma presently on the market. So why would Opko even want to waste their money on this if they already know there are approved drugs for this ? This is why Opko's stock price only moved 2 pennies on this News.
0 · Reply
tymtested
tymtested Apr. 22 at 6:07 PM
$OPK Once ModeX has completely proven their approach with a successful project, the approach will probably be more valuable than the project, thus big pharma pays a premium!! GO OPKO!
0 · Reply
tymtested
tymtested Apr. 22 at 6:02 PM
$OPK Another big pharma will pay $10 long before the market ever gets there.
0 · Reply
tradertrash
tradertrash Apr. 22 at 5:44 PM
$OPK what if commodeX is successful ❓ but sh never see roi❓ like ray, hgh, covid testing❓ run it back thru r&d raisez and bonusez for mgt just continue the same shenanigans, CommodeX being successful doesn't mean sh*t if they don't change there MO
1 · Reply
Gasbagger
Gasbagger Apr. 22 at 5:21 PM
$OPK well it will only take 4 years for the MDX2003 phase 1 trial to be completed and that's if Opko is lucky. They require 180 participants and they have just begun recruiting.
0 · Reply
tymtested
tymtested Apr. 22 at 2:16 PM
$OPK Oh, I should have mentioned the low-ball guidance at the beginning of the year.... which everyone knows companies do so they can beat the rest of the year.
0 · Reply